The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jacobs Bruce N. since 2021.
This trader's CIK number is 1821074.
At the time of last reporting, Jacobs Bruce N. was the Chief Financial Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KYMR | 0 | $0 | 7,035 | $215,735 | 35,000 | $72,800 |
| 2024 | KYMR | 0 | $0 | 3,934 | $166,620 | 25,000 | $52,000 |
| 2023 | KYMR | 0 | $0 | 1,370 | $42,657 | 10,000 | $20,800 |
| 2022 | KYMR | 0 | $0 | 15,000 | $783,060 | 65,000 | $135,200 |
| 2021 | KYMR | 0 | $0 | 60,000 | $3,159,133 | 70,000 | $145,599 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-31 | KYMR | Option Ex | 25,000 | 2.08 | 52,000 |
| 2025-03-03 | KYMR | Sale | 7,035 | 30.67 | 215,735 |
| 2025-01-10 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2024-06-27 | KYMR | Option Ex | 25,000 | 2.08 | 52,000 |
| 2024-03-04 | KYMR | Sale | 3,934 | 42.35 | 166,620 |
| 2023-06-02 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2023-03-02 | KYMR | Sale | 1,370 | 31.14 | 42,657 |
| 2022-10-21 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-10-17 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-05-03 | KYMR | Option Ex | 20,000 | 2.08 | 41,600 |
| 2022-01-14 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-01-12 | KYMR | Option Ex | 15,000 | 2.08 | 31,200 |
| 2022-01-12 | KYMR | Sale | 15,000 | 52.20 | 783,060 |
| 2021-12-03 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-12-03 | KYMR | Sale | 10,000 | 54.23 | 542,320 |
| 2021-11-23 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-09-03 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-09-03 | KYMR | Sale | 10,000 | 60.27 | 602,740 |
| 2021-03-11 | KYMR | Sale | 1,805 | 60.07 | 108,431 |
| 2021-03-11 | KYMR | Option Ex | 1,805 | 2.08 | 3,754 |
| 2021-03-15 | KYMR | Sale | 8,195 | 60.17 | 493,093 |
| 2021-03-15 | KYMR | Option Ex | 8,195 | 2.08 | 17,045 |
| 2021-03-08 | KYMR | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-03-08 | KYMR | Sale | 10,000 | 51.30 | 512,950 |
| 2021-03-03 | KYMR | Option Ex | 20,000 | 2.08 | 41,600 |
| 2021-03-03 | KYMR | Sale | 20,000 | 44.98 | 899,599 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jacobs Bruce N. (Chief Financial Officer of Kymera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.